A Modified Anastomosis Technique for Esophagojejunostomy after Laparoscopy-Assisted Total Gastrectomy: A Single Team Preliminary Experience
Table 1
Clinicopathological information of the patients in the cRY group and the pRY group.
Variable
cRY group ()
pRY group ()
value
Age (years)
0.238
Sex(M/F)
29/15
41/27
0.468
BMI (kg/m2)
24.0 ± 2.1
0.197
Neoadjuvant therapy
5 (11.4%)
9 (13.2%)
0.770
Preoperative comorbidities (total)
16 (36.4%)
22 (32.3%)
0.662
Hypertension
7 (15.9%)
10 (14.7%)
0.862
Diabetes mellitus
4 (9.1%)
5 (7.4%)
1.000
Heart disease
1 (2.3%)
2 (2.9%)
1.000
Chronic lung disease
2 (4.5%)
3 (4.4%)
1.000
Other comorbidities
2 (4.5%)
2 (2.9%)
1.000
History of laparotomy
6 (13.6%)
8 (11.8%)
0.770
ASA score (I:II:III)
25: 17: 2
35: 30 : 3
0.846
Tumor location
0.719
EGJ
27
44
Gastric body
17
24
TNM stagea (I:II:III)
10: 20: 14
7: 38: 23
0.191
Values are presented as , number, or number (%). ASA score: American Society of Anesthesiologists score; BMI: body mass index; EGJ: esophagogastric junction. aTNM stage was evaluated according to the 8th edition of the AJCC Staging Manual.
